Johnson & Johnson's Zytiga Helps Increase Survival Rate For Patient With Severe Prostate Cancer Medicine & Technology Jun 05, 2017 American Society of Clinical Oncology (ASCO) presented the research of the effectiveness of Zytiga to boost the survival rate for severe prostate cancers.
SPACE Supercluster Catalog Identified in the Sloan Digital Sky Survey; Einasto Recorded as the Most Massive Galaxy Group
SPACE Megaconstellations From Dead Satellites Could Weaken Earth’s Magnetic Field, Cause Atmospheric Stripping
SPACE James Webb Telescope Spots Complex Organic Molecules Near Forming Stars, Revealing Planetary Origins